SelSym Biotech
Durham, US · North Carolina corporation
Founders & leadership
SN
Seema NandiNamed on SEC filing
Board
LL
Louis LyonBoard director
WH
William HeathBoard director
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2026
▶$500KraisedJul 2026 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedJul 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Seema NandiExecutive Officer, Director
- Louis LyonDirector
- William HeathDirector
- Offering amount
- $1.5M
- Amount sold
- $500K
- First sale
- Jul 2026
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Persephoni Backs SelSym Biotech to Bring Blood-Type-Agnostic Bleeding Control to the Point of Injuryindovizka.com · Jul 2026Frequently asked questions
- How much funding has SelSym Biotech raised?
- SelSym Biotech has disclosed $500K raised across 1 round.
- Where is SelSym Biotech headquartered?
- SelSym Biotech is headquartered in Durham, US.